
Nutriband Inc.
NTRBHealthcare|Biotechnology|US
$5.55
-0.03 (-0.45%)
Tangible Book / Share
$0.28
Cash / Share
$0.28
Next Earnings Report
Dec 7, 2026
Revenue est. $465.0K
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Feb 13, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274
Oct 13, 2026 · GlobeNewsWire
Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology
Oct 8, 2026 · GlobeNewsWire
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
Oct 1, 2026 · GlobeNewsWire
Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis
Sep 29, 2026 · GlobeNewsWire
Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing
Sep 22, 2026 · GlobeNewsWire
Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit
Sep 9, 2026 · GlobeNewsWire
Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch
Sep 8, 2026 · GlobeNewsWire
Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight
Aug 13, 2026 · GlobeNewsWire
SEC Filings (37)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Sep 30, 2026 | 25-NSE | DocumentIndex | |
| Sep 23, 2026 | 8-K | Material event | DocumentIndex |
| Sep 15, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Sep 4, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jun 22, 2026 | 8-K | Material event | DocumentIndex |
| Jun 11, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 18, 2026 | 10-K/A | Annual report | DocumentIndex |
| Apr 29, 2026 | 10-K | Annual report | DocumentIndex |
| Apr 7, 2026 | 8-K | Material event | DocumentIndex |
| Feb 13, 2026 | 8-K | Material event | DocumentIndex |
| Feb 13, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Feb 3, 2026 | 8-K | Material event | DocumentIndex |
| Dec 30, 2025 | 8-K | Material event | DocumentIndex |
| Dec 19, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Dec 11, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Oct 28, 2025 | 8-K | Material event | DocumentIndex |
| Oct 20, 2025 | 424B3 | Offering prospectus | DocumentIndex |
| Sep 9, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Sep 3, 2025 | 8-K | Material event | DocumentIndex |
| Aug 7, 2025 | 8-K | Material event | DocumentIndex |
| Jul 16, 2025 | 8-K | Material event | DocumentIndex |
| Jul 8, 2025 | 424B4 | Offering prospectus | DocumentIndex |
| Jul 3, 2025 | EFFECT | DocumentIndex | |
| Jul 3, 2025 | POS AM | DocumentIndex | |
| Jun 23, 2025 | POS AM | DocumentIndex | |
| May 30, 2025 | 10-Q | Quarterly report | DocumentIndex |
| May 13, 2025 | 10-K/A | Annual report | DocumentIndex |
| Apr 28, 2025 | 10-K | Annual report | DocumentIndex |
| Apr 9, 2025 | 8-K | Material event | DocumentIndex |
| Mar 13, 2025 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| Mar 13, 2025 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| Feb 13, 2025 | 8-K | Material event | DocumentIndex |
| Feb 12, 2025 | 8-K | Material event | DocumentIndex |
| Jan 29, 2025 | 8-K | Material event | DocumentIndex |
| Dec 30, 2024 | 8-K | Material event | DocumentIndex |
| Dec 16, 2024 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Dec 4, 2024 | 10-Q | Quarterly report | DocumentIndex |